CV SCIENCES OTCMKTSCVSI STOCK QUOTE

https://www.cvsciences.com/

LATEST NEWS FROM CV SCIENCES

CV Sciences, Inc. Announces Launch of +PlusCBD™ Pain Relief Topicals

CV Sciences, Inc. Announces New Distribution Agreement with GNC

CV Sciences, Inc. Appoints Haskell & White LLP as Auditor

CV Sciences, Inc. Announces Convertible Note Financing

CV Sciences, Inc. Reports Third Quarter 2021 Financial Results

CV Sciences, Inc. to Announce Third Quarter 2021 Results on November 15, 2021

CV Sciences, Inc. Applauds the California Legislature for Passage of AB 45

CV Sciences, Inc. Reports Second Quarter 2021 Financial Results

CV Sciences, Inc. to Announce Second Quarter 2021 Results on August 12, 2021

CV Sciences, Inc. Receives NutraIngredients-USA 2021 Product of the Year: Immune Support Award

CV Sciences, Inc. and University of California, San Diego Publish Study of Cannabidiol Efficacy in Treating Nicotine Dependence

CV Sciences, Inc. Reports First Quarter 2021 Financial Results

CV Sciences, Inc. Announces Launch of PlusCBD™ Calm and Sleep Gummies

CV Sciences, Inc. to Announce First Quarter 2021 Results on May 13, 2021

CV Sciences and Alkemist Labs Form Partnership to Support the National Institute of Standards and Technology’s Cannabis Quality Assurance Program

CV Sciences, Inc. Reports Fiscal Year-End 2020 Financial Results

CV Sciences, Inc. to Announce Fiscal Year and Fourth Quarter 2020 Results on March 18, 2021